Organisation paid for research Program year 2025 Source: CMS Open Payments

Advanced Vision Research Institute

Neither a doctor nor a teaching hospital

Research payments

$400,054

151 payments

Through program year 2025, Advanced Vision Research Institute is reported as receiving $400,054 in research payments, across 151 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$367,831	142
2024	Research	$23,722	8
2023	Research	$8,500	1

Breakdown

Who paid Research payments · program years 2023–2025

Regeneron Pharmaceuticals, Inc. $382,266 148 payments
AbbVie, Inc. $9,288 2 payments
Genentech, Inc. $8,500 1 payment

Studies the money was for Research payments · program years 2023–2025

A Phase 3b Single-Arm Study of Aflibercept 8 mg in Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME) $320,794 120 payments
A Multicenter, Randomized, Double-Masked, Placebo-Controlled Phase 3 Study of the Efficacy, Safety, and Tolerability of Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration $51,972 26 payments
A Phase 3 Randomized, Double-Masked, Active-Controlled Study of the Efficacy and Safety of 8 MG Aflibercept in Participants with Macular Edema Following Retinal Vein Occlusion $9,500 2 payments
Iamd Observational Study $8,500 1 payment
Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy (RGX-314 SRLTFU) $4,892 1 payment
Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy $4,396 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.